Morgia G, Vespasiani G, Pareo RM, Voce S, Madonia M, Carini M, Ingrassia A, Terrone C, Gentile M, Carrino M, Giannantoni A,Blefari F, Arnone S, Santelli G, Russo GI; SPRITE investigators. Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study). BJU Int. 2018 Aug;122(2):317-325. doi: 10.1111/bju.14209. Epub 2018 Apr 16. PMID: 29569389.
Cannarella R, Calogero AE, Condorelli RA, Giacone F, Mongioi' LM, La Vignera S. Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3112-3120. doi: 10.26355/eurrev_201904_17595. PMID: 31002161.
Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. PMID: 23235581; PMCID: PMC7084061.
Amdii RE, Al' Shukri AS. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]. Urologiia. 2018 May;(2):114-120. Russian. PMID: 29901305.
Rossi A, Mari E, Scarno M, Garelli V, Maxia C, Scali E, Iorio A, Carlesimo M. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol. 2012 Oct- Dec;25(4):1167-73. doi: 10.1177/039463201202500435. PMID: 23298508.
Wessagowit V, Tangjaturonrusamee C, Kootiratrakarn T, Bunnag T, Pimonrat T, Muangdang N, Pichai P. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract. Australas J Dermatol. 2016 Aug;57(3):e76-82. doi: 10.1111/ajd.12352. Epub 2015 May 25. PMID: 26010505.
Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, Wang D, Wang G, Wang S, Liang C,Qiu S, Gu X, Liu J, Weng Z, Wu C, Wei Q, Xie L, Wu W, Cheng Y, Hu J, Wang Z, Zeng X. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind,Placebo-controlled Trial. Urology. 2019 Jul;129:172-179. doi: 10.1016/j.urology.2019.02.030. Epub 2019 Mar 14. PMID: 30880074.